Back to News
Market Impact: 0.1
CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
Source: Business Wire
Healthcare & Biotech
CEL-SCI has been invited to deliver a keynote address on its Multikine therapy at the 6th World Congress on Otology, Rhinology and Laryngology. The announcement indicates scientific and industry visibility for Multikine but provides no clinical data, regulatory update, financial metrics, or commercial milestone.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
CVM0.35
More News
- Illumina CEO on Q3 Results and Business Outlook
- UnitedHealth is finally getting its act together. I'm buying into the turnaround
- Swiss Firms Plan Investment Boost in China Drug, Finance Sectors
- Bernstein SocGen raises Eli Lilly stock price target on strong Q3 beat
- Freedom Broker raises Eli Lilly stock price target on GLP-1 demand
- Regeneron Q3 revenue tops estimates on Sanofi Dupixent profit; shares rise 4%